Skip to main navigation Skip to search Skip to main content

The cyclin-dependent kinase 8 (CDK8) inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway

  • Azlann Arnett
  • , Keagan G. Moo
  • , Kaitlin J. Flynn
  • , Thomas B. Sundberg
  • , Liv Johannessen
  • , Alykhan F. Shamji
  • , Nathanael S. Gray
  • , Thomas Decker
  • , Ye Zheng
  • , Vivian H. Gersuk
  • , Ziaur S. Rahman
  • , David E. Levy
  • , Isabelle J. Marié
  • , Peter S. Linsley
  • , Ramnik J. Xavier
  • , Bernard Khor

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The cyclin-dependent kinase 8 (CDK8) inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science